Intarcia Therapeutics anticipates filing for FDA approval at the end of the third quarter of 2016. At this year's ADA presentation, Julio Rosenstock, MD, said the insertion method for the novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results